Gross Profit (TTM) Chart

View Gross Profit (TTM) for ORYZF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -0.1475M
March 31, 2026 -0.15M
December 31, 2025 -0.151M
September 30, 2025 -0.1533M
June 30, 2025 -0.1565M
March 31, 2025 -0.1564M
December 31, 2024 -0.1598M
September 30, 2024 -0.1614M
June 30, 2024 -0.1622M
March 31, 2024 -0.1639M
December 31, 2023 -0.1653M
September 30, 2023 -0.1687M
June 30, 2023 -0.1717M
March 31, 2023 -0.1755M
December 31, 2022 -0.175M
September 30, 2022 -0.131M
June 30, 2022 -0.128M
Date Value
March 31, 2022 -0.1237M
September 30, 2021 -0.1255M
June 30, 2021 -0.1658M
March 31, 2021 -0.1653M
December 31, 2020 -0.1654M
September 30, 2020 -0.1644M
June 30, 2020 -0.1664M
March 31, 2020 -0.1674M
December 31, 2019 -0.1675M
September 30, 2019 -0.1678M
June 30, 2019 -0.1673M
March 31, 2019 -0.1715M
December 31, 2018 -0.1729M
September 30, 2018 0.317M
June 30, 2018 0.3587M
March 31, 2018 0.4052M
March 31, 2016 0.4475M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Pharma Mar SA 228.39M
Grifols SA 3.201B
ACADIA Pharmaceuticals, Inc. 1.038B
Alkermes Plc 1.370B
Alnylam Pharmaceuticals, Inc. 3.827B